| 1 |
Ling Q, Chen J, Liu X, Xu Y, Ma J, Yu P, Zheng K, Liu F, Luo J. The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose-response meta-analysis. Front Endocrinol (Lausanne) 2022;13:1043169. [PMID: 36743937 DOI: 10.3389/fendo.2022.1043169] [Reference Citation Analysis]
|
| 2 |
刘 艳. Research Progress of TyG Index and IR in Cognitive Impairment of Type 2 Diabetes Mellitus. ACM 2023;13:415-419. [DOI: 10.12677/acm.2023.131063] [Reference Citation Analysis]
|
| 3 |
Hao S, Ming L, Li Y, Lv H, Li L, Jambal T, Ji R. Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.1072133] [Reference Citation Analysis]
|
| 4 |
Wang J, Yan S, Cui Y, Chen F, Piao M, Cui W. The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis. Nutrients 2022;14. [PMID: 36500999 DOI: 10.3390/nu14234969] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 5 |
Zhang R, Guan Q, Zhang M, Ding Y, Tang Z, Wang H, Zhang W, Chen Y, Jiang R, Cui Y, Wang J. Association Between Triglyceride-Glucose Index and Risk of Metabolic Dysfunction-Associated Fatty Liver Disease: A Cohort Study. Diabetes Metab Syndr Obes 2022;15:3167-79. [PMID: 36268197 DOI: 10.2147/DMSO.S383907] [Reference Citation Analysis]
|
| 6 |
Wang F, Wang J, Han Y, Shi X, Xu X, Hou C, Gao J, Zhu S, Liu X. Triglyceride-glucose index and stroke recurrence in elderly patients with ischemic stroke. Front Endocrinol 2022;13:1005614. [DOI: 10.3389/fendo.2022.1005614] [Reference Citation Analysis]
|
| 7 |
Li D, Zhang M, Wu S, Tan H, Li N. Risk factors and prediction model for nonalcoholic fatty liver disease in northwest China. Sci Rep 2022;12:13877. [PMID: 35974018 DOI: 10.1038/s41598-022-17511-6] [Reference Citation Analysis]
|
| 8 |
Liu Z, He H, Dai Y, Yang L, Liao S, An Z, Li S. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study. Lipids Health Dis 2022;21:55. [PMID: 35752830 DOI: 10.1186/s12944-022-01661-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 9 |
Alalwani J, Eljazzar S, Basil M, Tayyem R. The impact of health status, diet and lifestyle on non‐alcoholic fatty liver disease: Narrative review. Clinical Obesity. [DOI: 10.1111/cob.12525] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Liu Y, Wang W. Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults. Lipids Health Dis 2022;21:8. [PMID: 35027066 DOI: 10.1186/s12944-021-01617-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
李 雯. Research Progress of Triglyceride Glucose Product Index and Insulin Resistance in Re-nal Disease. ACM 2022;12:3550-3558. [DOI: 10.12677/acm.2022.124515] [Reference Citation Analysis]
|
| 12 |
Wang J, Su Z, Feng Y, Xi R, Liu J, Wang P. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China. BMC Gastroenterol 2021;21:482. [PMID: 34923965 DOI: 10.1186/s12876-021-02072-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Liu J, Guan L, Zhao M, Li Q, Song A, Gao L, Lin H, Zhao J. Association Between the Triglyceride-Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study. Diabetes Metab Syndr Obes 2021;14:2829-39. [PMID: 34188506 DOI: 10.2147/DMSO.S316864] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
